Year: 2019
Type: article
Source: JACC Heart Failure
Institutions: Duke University, Duke Medical Center, University of California, Los Angeles, University of Mississippi Medical Center, Stanford Medicine, Verily Life Sciences LLC (United States), Stanford University, Emory University, Brigham and Women's Hospital, Harvard University, Northwestern University, Inova Health System
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: American Heart Association, Boehringer Ingelheim, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Roche, Sanofi, Medtronic, Gilead Sciences, Patient-Centered Outcomes Research Institute, Boston Scientific Corporation, Abraham J. and Phyllis Katz Foundation, Bayer Fund, Luitpold Pharmaceuticals, ResMed, Verily Life Sciences, European Commission, Daiichi-Sankyo, National Institutes of Health, U.S. Food and Drug Administration, Genentech, Baxter Healthcare Corporation, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences, Duke Clinical Research Institute, Janssen Pharmaceuticals
OpenAlex ID: W2979761728